Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. SPY
3. ACVA
4. RIOT
5. RPD
6. CRWV
7. FERG
8. NVDA
9. HIMS
10. BBIO

Go back to Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
(NASDAQ: LEXX) Delayed: 5.79 +0.30 (5.46%)
Previous Close $5.49    52 Week High $ 
Open $5.50    52 Week Low $ 
Day High $5.99    P/E N/A 
Day Low $5.50    EPS $ 
Volume 8,775